The lipid analysis test results were subjected to many drawbacks during patient handling such as
inaccuracy in the results due to improper fasting and medications, human error, and various other
factors, which gives false negative or false positive results. Therefore, to overcome such drawbacks,
lipid analysis market demands for new technology-based devices, which will propel growth of lipid
analysis devices market. According to the American Diabetes Association, heart attack or stroke
affect people with diabetes more than twice as often as people without diabetes. Therefore, Polymer
Technology Systems Diagnostics, in 2013, introduced CardioChek Plus analyzer at the annual
American Association for Clinical Chemistry (AACC), which can be used for analyzing both lipid
and glucose levels simultaneously. Furthermore, the CardioChek Plus analyzer system is Wi-Fi
enabled and can transmit test results of patients to data collection applications. In 2013, Acon
Laboratories, Inc., launched the Mission Cholesterol Monitoring system, which can perform 3 tests;
total cholesterol (CHOL), high density lipoprotein (HDL), and triglycerides (TRIG).
Lipid disorder is a medical condition where the patient has elevated levels of plasma cholesterol or
triglycerides (TG), or both, or a low high-density lipoprotein (HDL) level, which leads to long-term
problems such as atherosclerosis, elevated blood pressure, obesity, and diabetes mellitus.
Dyslipidemia is a metabolic syndrome where blood lipid levels are elevated leading to increased
risk of coronary heart disease (CHD). For instance, according to Registrar General of India,
coronary heart disease led to around 17% of the total deaths in 2001-2003, which increased to
around 23% in 2010-2013. According to the Centers for Disease Control and Prevention (CDC), in
2015, high blood cholesterol was the leading cause of death in the U.S. and people with high
cholesterol had about twice the risk of heart disease, as compared to people with lower cholesterol
level. Such high prevalence of high cholesterol and coronary heart disease globally is expected to
propel growth of the lipid analysis device market. Furthermore, increasing awareness of lipid
analysis devices especially kits among the population is expected to drive growth of the market.
For More Information @ https://www.coherentmarketinsights.com/ongoing-insight/lipid-
analysis-devices-market-1488
Lipid Analysis Devices Market – Regional Analysis
On the basis of region, the global lipid analysis devices market is segmented into North America,
Latin America, Europe, Asia Pacific, Middle East, and Africa. Lipid analysis devices market is
predominant in Europe region due to sedentary lifestyle and high fat diet, which contributes to
increasing incidence of abnormal levels of lipid leading to cardiovascular disease. According to the
World Health Organization (WHO), in 2008, around 133 million people suffered from bad
cholesterol in 5 economies of European Union, which includes Germany, France, Italy, Spain, and
UK. Moreover, Asia Pacific is expected to be the fastest growing lipid analysis devices market
region due to increasing healthcare awareness and diagnostic demand.
Lipid Analysis Devices Market – Competitors
Polymer Technology Systems, Inc., Jant Pharmacal Corporation, Alere, F. Hoffmann-La Roche
Ltd., Acon Laboratories, Inc., and Cholestech Corporation are some of the major players in the lipid